- Forums
- ASX - By Stock
- ACR
- Ann: Acrux's seventh generic dossier accepted by FDA for review
Ann: Acrux's seventh generic dossier accepted by FDA for review, page-7
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $13.08M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.4¢ | $10.91K | 243.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 79022 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 79022 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
5 | 442500 | 0.040 |
1 | 78000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.047 | 20590 | 1 |
0.048 | 44500 | 3 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
Last trade - 15.11pm 15/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online